Andtbacka, R. H. I., Agarwala, S. S., Ollila, D. W., Hallmeyer, S., Milhem, M., Amatruda, T., . . . Kaufman, H. L. (2016). Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head Neck.
Citación estilo ChicagoAndtbacka, Robert H. I., et al. "Cutaneous Head and Neck Melanoma in OPTiM, a Randomized Phase 3 Trial of Talimogene Laherparepvec Versus Granulocyte‐macrophage Colony‐stimulating Factor for the Treatment of Unresected Stage IIIB/IIIC/IV Melanoma." Head Neck 2016.
Cita MLAAndtbacka, Robert H. I., et al. "Cutaneous Head and Neck Melanoma in OPTiM, a Randomized Phase 3 Trial of Talimogene Laherparepvec Versus Granulocyte‐macrophage Colony‐stimulating Factor for the Treatment of Unresected Stage IIIB/IIIC/IV Melanoma." Head Neck 2016.